Russell Investments Group, Ltd. Mirati Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$41.99 - $62.38 $223,764 - $332,423	-5,329 Reduced 95.25%	266 $15,000
Q3 2023 Nov 13, 2023	SELL	$27.8 - $45.35 $1.47 Million - $2.4 Million	-53,002 Reduced 90.45%	5,595 $243,000
Q2 2023 Aug 10, 2023	SELL	$36.13 - $49.49 $205,110 - $280,954	-5,677 Reduced 8.83%	58,597 $2.12 Million
Q1 2023 May 09, 2023	BUY	$36.54 - $54.26 $155,221 - $230,496	4,248 Added 7.08%	64,274 $2.39 Million
Q4 2022 Feb 08, 2023	BUY	$41.27 - $98.62 $1.37 Million - $3.27 Million	33,186 Added 123.64%	60,026 $2.72 Million
Q3 2022 Nov 04, 2022	BUY	$59.5 - $86.7 $160,709 - $234,176	2,701 Added 11.19%	26,840 $1.87 Million
Q2 2022 Jul 29, 2022	SELL	$39.16 - $88.71 $1.34 Million - $3.03 Million	-34,115 Reduced 58.56%	24,139 $1.62 Million
Q1 2022 May 05, 2022	BUY	$75.82 - $150.97 $746,675 - $1.49 Million	9,848 Added 20.34%	58,254 $4.79 Million
Q4 2021 Jan 21, 2022	BUY	$132.01 - $190.29 $1.28 Million - $1.84 Million	9,680 Added 25.0%	48,406 $7.1 Million
Q3 2021 Nov 08, 2021	BUY	$132.13 - $177.45 $685,754 - $920,965	5,190 Added 15.48%	38,726 $6.85 Million
Q2 2021 Aug 04, 2021	BUY	$144.0 - $179.73 $2.96 Million - $3.7 Million	20,589 Added 159.03%	33,536 $5.42 Million
Q1 2021 May 10, 2021	SELL	$158.92 - $221.61 $4.44 Million - $6.19 Million	-27,913 Reduced 68.31%	12,947 $2.22 Million
Q4 2020 Feb 08, 2021	BUY	$162.05 - $240.27 $931,139 - $1.38 Million	5,746 Added 16.36%	40,860 $8.97 Million
Q3 2020 Nov 09, 2020	BUY	$113.26 - $167.27 $1.62 Million - $2.4 Million	14,338 Added 69.01%	35,114 $5.83 Million
Q2 2020 Aug 05, 2020	SELL	$72.01 - $120.39 $286,743 - $479,392	-3,982 Reduced 16.08%	20,776 $2.37 Million
Q1 2020 May 06, 2020	SELL	$69.78 - $116.21 $315,684 - $525,734	-4,524 Reduced 15.45%	24,758 $1.91 Million
Q4 2019 Jan 29, 2020	BUY	$70.76 - $128.86 $490,862 - $893,901	6,937 Added 31.04%	29,282 $3.77 Million
Q3 2019 Nov 01, 2019	SELL	$77.91 - $109.6 $14,413 - $20,276	-185 Reduced 0.82%	22,345 $1.75 Million
Q2 2019 Aug 09, 2019	BUY	$59.49 - $104.71 $2,141 - $3,769	36 Added 0.16%	22,530 $2.32 Million
Q1 2019 May 13, 2019	BUY	$43.65 - $78.95 $981,863 - $1.78 Million	22,494 New	22,494 $1.65 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account